Mylan NV (MYL.O)

MYL.O on Nasdaq

59.71USD
11:00am EDT
Change (% chg)

$-0.29 (-0.48%)
Prev Close
$60.00
Open
$59.56
Day's High
$60.00
Day's Low
$58.90
Volume
1,398,796
Avg. Vol
4,010,582
52-wk High
$65.63
52-wk Low
$44.74

MYL.O

Chart for MYL.O

About

Mylan N.V., formerly Mylan Inc., is a global pharmaceutical company, which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals. Mylan operates in two segments: Generics and Specialty. The Company’s generic pharmaceutical business is conducted primarily in the United... (more)

Overall

Beta: 1.23
Market Cap(Mil.): $29,303.31
Shares Outstanding(Mil.): 488.39
Dividend: --
Yield (%): --

Financials

  MYL.O Industry Sector
P/E (TTM): 25.69 40.53 41.01
EPS (TTM): 2.34 -- --
ROI: 8.16 16.83 16.17
ROE: 29.99 17.37 17.02
Search Stocks

UPDATE 1-Mylan still on the prowl for deals, perhaps one by end 2015

March 2 - U.S. generic drug maker Mylan Inc is still on the prowl for more deals, after completing the multibillion-dollar acquisition of some of Abbott Laboratories' non-U.S. businesses just last week.

02 Mar 2015

Drugmaker Mylan's fourth-quarter profit rises on strong demand in North America

- Generic and specialty drugmaker Mylan Inc reported a rise in quarterly profit and revenue, driven mainly by strong demand for its generics in North America.

02 Mar 2015

Drugmaker Mylan's 4th-qtr profit rises on strong demand in N. America

March 2 - Generic and specialty drugmaker Mylan Inc reported a rise in quarterly profit and revenue, driven mainly by strong demand for its generics in North America.

02 Mar 2015

What to Watch in the Week Ahead and on Monday, Mar. 2

(The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at . Thomson One users can register at RT/DAY/US. All times in ET/GMT) WEEK AHEAD

27 Feb 2015

Mylan buys female health businesses from Indian drugmaker

- Mylan Inc said it would buy Indian drugmaker Famy Care Ltd's female health businesses for about $750 million in cash and $50 million in contingent payments to expand its line of women's health products.

02 Feb 2015

UPDATE 1-Mylan buys female health businesses from Indian drugmaker

Feb 2 - Mylan Inc said it would buy Indian drugmaker Famy Care Ltd's female health businesses for about $750 million in cash and $50 million in contingent payments to expand its line of women's health products.

02 Feb 2015

Mylan buys female health businesses from Indian drugmaker

Feb 2 - Mylan Inc said it would buy Indian drugmaker Famy Care Ltd's female health businesses to expand its line of women's health products.

02 Feb 2015

EU approves Mylan purchase of Abbot generics, subject to conditions

BRUSSELS - The European Commission approved on Wednesday the acquisition of Abbot Laboratories' non-U.S. Developed Markets Specialty and Branded Generics Business (Abbott EPD-DM) by the U.S. based producer of generic pharmaceuticals Mylan Inc, subject to conditions.

28 Jan 2015

EU mergers and takeovers (Jan 28)

BRUSSELS, Jan 28 - The following are mergers under review by the European Commission and a brief guide to the EU merger process:

28 Jan 2015

EU approves Mylan purchase of Abbot generics, subject to conditions

BRUSSELS - The European Commission approved on Wednesday the acquisition of Abbot Laboratories' non-U.S. Developed Markets Specialty and Branded Generics Business (Abbott EPD-DM) by the U.S. based producer of generic pharmaceuticals Mylan Inc , subject to conditions.

28 Jan 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks